Acting on sex and gender in medical innovation is good for business

Lavanya Vijayasingham; Evelyne Bischof; Bernadette Ateghang-Awankem; Maryam Rumaney; Mariam Otmani Del Barrio; Phaik Yeong Cheah; Ajoke Sobanjo Ter-Meulen; Cara Tannenbaum; Rosemary Morgan; Jeannette Wolfe; Gender and Covid-19 Research Agenda Setting Initiative

doi:10.1136/bmj-2022-072242

Acting on sex and gender in medical innovation is good for business

BMJ. 2023 Jun 7:381:e072242. doi: 10.1136/bmj-2022-072242.

Authors

Affiliations

¹ London School of Hygiene and Tropical Medicine, London, UK Lavanya.Vijayasingham@lshtm.ac.uk.
² Shanghai University of Medicine and Health Sciences, College of Basic Medicine, Shanghai, China.
³ Renji University Hospital of Jiatong School of Medicine, Renji, Shanghai, China.
⁴ International Center for Multimorbidity and Complexity in Medicine (ICMC), Universität Zürich, Switzerland.
⁵ Global Health Division, Pan African Health Systems Network, Nussloch, Germany.
⁶ Cape Town, South Africa.
⁷ Mahidol-Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Thailand.
⁸ Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
⁹ Department of Global Health, University of Washington, Seattle, USA.
¹⁰ Faculties of Medicine and Pharmacy at the Université de Montréal, Québec, Canada.
¹¹ Institute of Gender and Health, Canadian Institutes of Health Research, Canada.
¹² Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
¹³ Department of Emergency Medicine, UMass Chan Medical School-Baystate Campus, Springfield, USA.

Abstract

Lavanya Vijayasingham and colleagues argue that as well as improving safety and efficacy, considering sex and gender related factors in medical research can have commercial benefits

MeSH terms

Commerce*
Humans
Organizational Innovation